Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

nitto medic co., ltd. - betaxolol hydrochloride - colorless to slightly yellow limpid ophthalmic solution, 5 ml, (cap) white, (label) white label with pale purple band, (bottle) clear

Estats Units - anglès - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride ophthalmic solution, 2% is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride ophthalmic solution, 2% is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1)]. teratogenic effects pregnancy category c developmental toxicity studies with dorzolamide hydrochloride in rabbits at oral doses of ≥ 2.5 mg/kg/day revealed malformations of the vertebral bodies. these malformations occurred at doses that caused metabolic acidosis with decreased body weight gain in dams and decreased fetal weights. no treatment-related malformations were seen at 1 mg/kg/day. these doses represent estimated plasma cmax levels in rabbits, 37 and 15 times higher than the lower limit of detection in human plasma following ocular administration, respectively. there are no adequate and well-controlled studies in pregnant women. dorzolamide hydrochloride op

Malta - anglès - Medicines Authority

s.a alcon-couvreur n.v. - betaxolol hydrochloride 2.5 mg/ml - eye drops, suspension

Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - betaxolol hydrochloride -

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

immedica pharma ab - betaxolol hydrochloride - eye drops - 2.5mg/1ml

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - betaxolol hydrochloride 5,6 mg/ml - eq. betaxolol 5 mg/ml - eye drops, solution - 5 mg/ml - betaxolol hydrochloride 5.6 mg/ml - betaxolol

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - betaxolol hydrochloride 2,8 mg/g - eq. betaxolol 2,5 mg/g - eye drops, suspension - 2,5 mg/ml - betaxolol hydrochloride 2.8 mg/g - betaxolol

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - betaxolol hydrochloride 2,8 mg/ml - eq. betaxolol 2,5 mg/ml - eye drops, suspension - 2,5 mg/ml - betaxolol hydrochloride 2.8 mg/ml - betaxolol

Kenya - anglès - Pharmacy and Poisons Board

ashford laboratories ltd ashford laboratories ltd., no. 131-133, av. do - betaxolol hydrochloride - eye drops, solution - each 1ml contains 5mg of betaxolol hydrochloride… - ophthalmological antiglaucoma preparations and

Canadà - anglès - Health Canada

novartis pharmaceuticals canada inc - betaxolol (betaxolol hydrochloride) - suspension - 0.25% - betaxolol (betaxolol hydrochloride) 0.25% - beta-adrenergic agents